Hepatitis Treatment Archives - Competition Policy International

Home Tags Hepatitis Treatment

US: Arrowhead, Janssen sign US$3.7b license and collaboration deal

CPI - October 11, 2018

Arrowhead Pharmaceuticals has signed a license and collaboration agreement with Janssen Pharmaceuticals for the development and commercialization of hepatitis B virus (HBV) treatment, ARO-HBV. ARO-HBV...

News

Congressional Committee Hearing Heats Up As House Republicans Slam FTC Budget

CPI

July 13, 2023

French Government Criticizes Appointment Of US Economist As Chief Antitrust Advisor

CPI

July 13, 2023

PGA Tour And Saudi Arabia’s Public Investment Fund Drop No-Poaching Clause

CPI

July 13, 2023

Boies Schiller Flexner Grows Antitrust Team

CPI

July 13, 2023

Professors Hit Texas’ TikTok Ban With First Amendment Suit

CPI

July 13, 2023

Enable Notifications OK No thanks

Tag: Hepatitis Treatment

US: Arrowhead, Janssen sign US$3.7b license and collaboration deal

News

Congressional Committee Hearing Heats Up As House Republicans Slam FTC Budget

French Government Criticizes Appointment Of US Economist As Chief Antitrust Advisor

PGA Tour And Saudi Arabia’s Public Investment Fund Drop No-Poaching Clause

Boies Schiller Flexner Grows Antitrust Team

Professors Hit Texas’ TikTok Ban With First Amendment Suit

About CPI

Get Started

Stay Connected

Sign up for our free Newsletter